Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 242 member A (FAM242A), also known as LINC01598 or long intergenic non-protein coding RNA 1598, is a **long intergenic non-coding RNA (lincRNA)**. It does not encode a protein or receptor, and its physiological function remains uncharacterized. LincRNAs such as FAM242A are typically involved in **gene regulation at the transcriptional or chromatin level**, often acting in a context-dependent or cell-type-specific manner[1][2][5]. FAM242A is currently not considered a therapeutic target, and there are no defined disease associations, biomarkers, or drug interactions for this gene in the available literature. The biology of lincRNAs suggests they may influence cell identity, differentiation, or stress responses, but these roles have not been specifically attributed to FAM242A[1][2][5].
None known (lincRNAs generally do not represent conventional drug targets and no mechanisms established for FAM242A)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 242 member A (FAM242A).